Reviewed by Dr. Mark A. Cappel, MD, Double Board-Certified Dermatologist and Dermatopathologist, Founder of Dermagnify | Ponte Vedra Beach, FL
Dysport and Botox are the two most frequently compared neurotoxins in cosmetic dermatology, and the comparison is a reasonable one to want to understand. Both are FDA-approved botulinum toxin type A injectables that temporarily relax targeted facial muscles to smooth dynamic wrinkles. They work through the same fundamental mechanism, are used for the same indications, and produce results that most people describe in essentially the same terms.
And yet they are not interchangeable. They are formulated differently, dosed differently, and have subtly distinct clinical profiles that make one a better fit than the other in specific situations. At Dermagnify in Ponte Vedra Beach, Florida, I offer both products and select between them based on the patient's anatomy, the treatment area, their timeline, and their results history. Here is the clinical breakdown.
What Botox and Dysport Actually Are
Both Botox and Dysport are botulinum toxin type A formulations. They work by binding to nerve terminals at the neuromuscular junction and preventing the release of acetylcholine, the neurotransmitter that signals muscles to contract. Without that signal, the targeted muscle temporarily relaxes, and the dynamic wrinkles it produces soften or disappear.
Botox (onabotulinumtoxinA) is manufactured by Allergan (now AbbVie). It received FDA approval for cosmetic use in 2002 and remains the most recognized name in this category. Dysport (abobotulinumtoxinA) is manufactured by Galderma and received FDA approval for cosmetic use in 2009. Both are used to treat glabellar lines, forehead lines, and crow's feet, among other applications.
What differs is not the mechanism but the formulation: the specific protein complex surrounding the active toxin, the stabilizing excipients, and the resulting clinical behavior in tissue.
The Key Clinical Differences
Onset: Dysport Works Faster
This is one of the most consistent and clinically meaningful differences. Dysport typically begins producing visible results within 1 to 3 days of injection, while Botox generally takes 3 to 7 days before initial effects are noticed. Both products reach their full effect at approximately 14 days.
For patients with a specific event on the calendar, Dysport's faster onset is a practical advantage. It also reduces the uncertainty window in the first week when patients sometimes wonder if the treatment is working. For patients without time constraints, the onset difference is largely inconsequential since the final result at two weeks is equivalent.
Diffusion: The Most Clinically Important Difference
Dysport has a broader diffusion pattern than Botox, meaning it spreads somewhat more widely through tissue from the injection point. This is not a flaw. It is a clinically useful property in some contexts and a liability in others, which is why it influences product selection by treatment area rather than representing a blanket advantage or disadvantage.
For larger surface areas like the forehead, where smooth, even coverage is the goal, Dysport's broader diffusion can reduce the number of injection points needed while producing uniform relaxation of the frontalis muscle. For smaller or more anatomically sensitive areas, Botox's more contained diffusion gives the injector more precise control.
The periorbital area around the eyes illustrates this well. Treating crow's feet involves injections close to the delicate tissue and muscles responsible for eye opening. A product that spreads too broadly in this area risks inadvertently affecting adjacent musculature. Botox's more localized diffusion is generally preferred here, while Dysport may be the better choice for the broad frontalis or the corrugator complex.
Unit Conversion: They Are Not Dosed the Same Way
This is the most common source of confusion for patients who have used both products across different practices. Botox units and Dysport units are not equivalent. The generally accepted conversion ratio is approximately 2.5 Dysport units for every 1 Botox unit to achieve comparable clinical effect, though this ratio varies by treatment area and patient anatomy.
This means that comparing prices by unit is meaningless across these two products. A practice charging less per Dysport unit will often be using significantly more units, producing a comparable or higher total session cost. The only meaningful cost comparison is total session cost for the same treatment area and result.
Duration: Comparable With Individual Variation
Both Botox and Dysport last approximately 3 to 4 months in most patients. Some Dysport patients report their results persisting slightly longer, particularly in larger muscle groups, but the clinical literature does not show a consistent, statistically significant duration advantage for either product across all patients and areas.
Individual variation in duration is more pronounced than the difference between products. Metabolism, muscle mass and activity level, dose accuracy, and treatment consistency all affect how long results last more than the choice of product.
Side-by-Side Comparison
| Feature | Botox | Dysport |
|---|---|---|
| Manufacturer | Allergan (AbbVie) | Galderma |
| Active ingredient | OnabotulinumtoxinA | AbobotulinumtoxinA |
| FDA cosmetic approval | 2002 | 2009 |
| Onset | 3 to 7 days | 1 to 3 days (typically faster) |
| Diffusion pattern | More localized | Broader spread in tissue |
| Duration | 3 to 4 months | 3 to 4 months |
| Unit conversion | Reference standard | Approx. 2.5:1 vs Botox units |
| Best for precision areas | Yes (crow's feet, lip flip) | Less ideal than Botox |
| Best for larger areas | Yes, with more injection points | Fewer points, natural coverage |
| Available at Dermagnify | Yes | Yes |
When Botox Is the Better Choice
- Crow's feet and periorbital treatment, where contained diffusion is essential to avoid affecting adjacent eye musculature
- Lip flip, where very small, precise doses are required in and around the orbicularis oris muscle
- Any treatment requiring highly localized placement in anatomically sensitive areas
- Patients with no time urgency who have an established, predictable Botox response and see no clinical reason to switch
When Dysport Is the Better Choice
- Forehead treatment, particularly in patients with a broader frontalis, where even coverage benefits from Dysport's diffusion pattern
- Glabellar lines in patients with prominent corrugator activity spanning a wider area
- Patients who need results before a specific event 1 to 2 weeks away and want the fastest possible onset
- Patients who have found Botox's duration at the short end of the range, where Dysport occasionally performs slightly longer
- Patients with a history of antibody resistance to Botox who have developed a reduced response over time with repeated treatment
How Dr. Cappel Chooses at Dermagnify
At Dermagnify, the selection between Dysport and Botox is a clinical decision made at your consultation based on the specific areas being treated, your anatomy, your prior treatment history with either product, and your timeline. I do not have a standing preference for one product over the other in the abstract. Each patient's face is anatomically distinct, and the treatment plan, including product choice, is built around that anatomy.
Patients who have established results with one product and are satisfied continue on that product. Patients who are new to neurotoxins begin a discussion that includes which product makes more clinical sense for their specific areas of concern, with an explanation of the reasoning. Some patients receive different products in different areas within the same appointment, which is an option when the treatment map includes both precision areas and larger surface areas.
I use Alma IQ advanced imaging at consultations to evaluate skin quality, texture, and facial structure, which informs both the treatment plan and the product selection for neurotoxin and combination protocols.
Learn more about Botox at Dermagnify and Dysport at Dermagnify, or explore our full range of neurotoxin options.
Dermagnify serves patients from Ponte Vedra Beach, Jacksonville, Jacksonville Beach, Atlantic Beach, St. Augustine, and throughout northeastern Florida.
Ready to Discuss Which Neurotoxin Is Right for You?
Book a neurotoxin consultation at Dermagnify in Ponte Vedra Beach, FL. Dr. Cappel will evaluate your anatomy and treatment history and recommend the right product and placement for your results.
100 Executive Way, Suite 114, Ponte Vedra Beach, FL 32082
Book a Consultation at Dermagnify.
Frequently Asked Questions: Dysport vs Botox
Is Dysport stronger than Botox?
No. Dysport and Botox are different products with different unit systems, not different strengths of the same product. When dosed appropriately using the correct conversion ratio (approximately 2.5 Dysport units to 1 Botox unit), both produce equivalent muscle relaxation in the treated area. Dysport is not a more powerful or more concentrated neurotoxin; it simply uses a different unit scale.
Does Dysport spread too much?
Dysport's broader diffusion pattern is a property, not a defect. In the hands of an experienced injector who selects Dysport for appropriate treatment areas, the diffusion produces natural, even coverage. The risk of unwanted spread is managed through product selection by area. At Dermagnify, Dr. Cappel does not use Dysport in areas where its diffusion pattern would be clinically disadvantageous for that patient's anatomy.
Can I switch from Botox to Dysport between appointments?
Yes. Switching between Botox and Dysport is clinically straightforward and common. The dose is recalculated using the appropriate conversion ratio. Some patients switch products intentionally after finding that one performs better for their specific anatomy or goals. Others switch because of product availability or cost. At Dermagnify, Dr. Cappel reviews your prior treatment history and adjusts dosing accordingly when a switch is made.
Why does Dysport cost different from Botox per unit?
Because Dysport uses a larger unit scale than Botox, the price per unit is typically lower. This can appear to make Dysport cheaper, but this comparison is misleading. A Dysport treatment requires approximately 2.5 times as many units as an equivalent Botox treatment. The relevant comparison is always the total session cost for the same treatment area and clinical outcome, not the per-unit price of the product.
How long does Dysport last compared to Botox?
Both Dysport and Botox typically last 3 to 4 months in most patients. Some Dysport patients report results lasting toward the longer end of that range in larger muscle groups. Individual metabolism, muscle mass, dose accuracy, and treatment consistency have more influence on duration than the product choice. If you find your neurotoxin results consistently fading at the shorter end of the range, this is worth discussing at your next appointment.
Does Dermagnify offer both Botox and Dysport in Ponte Vedra Beach, FL?
Yes. Dermagnify offers both Botox and Dysport at our Ponte Vedra Beach, Florida location. Dr. Mark A. Cappel, MD selects the appropriate product based on each patient's anatomy, treatment areas, and goals.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Neurotoxin treatments require individualized evaluation by a qualified provider. Please consult with Dr. Cappel at Dermagnify for a personalized recommendation. Individual results vary.